Condition
Internal Hemorrhoid
Total Trials
6
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting4
Unknown2
Clinical Trials (6)
Showing 6 of 6 trials
NCT06106269RecruitingPrimary
Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
NCT07635784Recruiting
Prospective HemorrhoIdaL EmboliSation (PILES) Registry
NCT04169152RecruitingPrimary
CAES for Internal Hemorrhoids and Rectal Prolapse
NCT03917056Not ApplicableRecruitingPrimary
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse
NCT06250140UnknownPrimary
Recurrence Rate of Minimally Invasive Endoscopic Treatment of Internal Hemorrhoids
NCT06031740Not ApplicableUnknown
A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids
Showing all 6 trials